First Eagle Investment Management LLC lessened its stake in Relx Plc (NYSE:RELX - Free Report) by 40.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,245,127 shares of the technology company's stock after selling 836,645 shares during the quarter. First Eagle Investment Management LLC owned about 0.07% of Relx worth $41,313,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in RELX. Arrowstreet Capital Limited Partnership grew its position in shares of Relx by 185.7% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 4,252,044 shares of the technology company's stock worth $140,955,000 after buying an additional 2,763,766 shares during the period. Bank of America Corp DE raised its position in shares of Relx by 14.3% in the 1st quarter. Bank of America Corp DE now owns 4,180,034 shares of the technology company's stock valued at $138,568,000 after acquiring an additional 522,619 shares during the period. Lazard Asset Management LLC raised its position in shares of Relx by 12.1% in the 1st quarter. Lazard Asset Management LLC now owns 3,040,217 shares of the technology company's stock valued at $100,783,000 after acquiring an additional 328,282 shares during the period. Royal Bank of Canada boosted its stake in Relx by 12.1% during the 1st quarter. Royal Bank of Canada now owns 1,736,295 shares of the technology company's stock worth $57,558,000 after acquiring an additional 187,132 shares during the last quarter. Finally, Sei Investments Co. boosted its stake in Relx by 25.3% during the 1st quarter. Sei Investments Co. now owns 528,854 shares of the technology company's stock worth $17,531,000 after acquiring an additional 106,777 shares during the last quarter. Institutional investors and hedge funds own 15.02% of the company's stock.
Relx Stock Performance
NYSE:RELX opened at $39.41 on Wednesday. The company has a current ratio of 0.45, a quick ratio of 0.40 and a debt-to-equity ratio of 5.23. The business's 50-day simple moving average is $36.94 and its 200-day simple moving average is $34.57. Relx Plc has a fifty-two week low of $27.57 and a fifty-two week high of $43.36.
Analyst Upgrades and Downgrades
RELX has been the subject of a number of analyst reports. JPMorgan Chase & Co. restated a "buy" rating on shares of Relx in a report on Tuesday, August 11th. TD Securities upgraded shares of Relx to a "strong-buy" rating in a report on Friday, September 11th. UBS Group reissued a "buy" rating on shares of Relx in a research report on Tuesday, September 29th. TD Cowen started coverage on shares of Relx in a report on Thursday, September 10th. They issued a "buy" rating for the company. Finally, Wall Street Zen cut shares of Relx from a "buy" rating to a "hold" rating in a research report on Sunday, September 13th. Two research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy".
Check Out Our Latest Stock Report on RELX
Relx Profile
(
Free Report)
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. Its operations are organized around scientific, technical and medical information; legal information and analytics; risk solutions; and exhibitions. The company's products and services include scientific journals and research platforms such as ScienceDirect and Scopus, legal research tools including LexisNexis, and analytics that help organizations assess risks, verify identities and detect fraud.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.